0001179110-16-024322.txt : 20160511
0001179110-16-024322.hdr.sgml : 20160511
20160511153903
ACCESSION NUMBER: 0001179110-16-024322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160509
FILED AS OF DATE: 20160511
DATE AS OF CHANGE: 20160511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FURLONG BRENDA J
CENTRAL INDEX KEY: 0001160223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 161639788
MAIL ADDRESS:
STREET 1: THE HARTFORD FINANCAIL SERVICES GROUP
STREET 2: HARTFORD PLAZA HO-1-09
CITY: HARTFORD
STATE: CT
ZIP: 06115
4
1
edgar.xml
FORM 4 -
X0306
4
2016-05-09
0
0001109354
BRUKER CORP
BRKR
0001160223
FURLONG BRENDA J
C/O BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
1
0
0
0
Common Stock
2016-05-09
4
M
0
6000
16.09
A
7000
D
Common Stock
2016-05-09
4
M
0
10000
16.42
A
17000
D
Common Stock
2016-05-09
4
M
0
6600
19.07
A
23600
D
Common Stock
2016-05-09
4
S
0
22600
27.4353
D
1000
D
Stock Option (right to buy)
16.09
2016-05-09
4
M
0
6000
0.00
D
2021-01-05
Common Stock
6000
0
D
Stock Option (right to buy)
16.42
2016-05-09
4
M
0
10000
0
D
2023-01-07
Common Stock
10000
0
D
Stock Option (right to buy)
19.07
2016-05-09
4
M
0
6600
0.00
D
2024-01-06
Common Stock
6600
3400
D
The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $27.34 to $27.60, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.
The option vested in three approximately equal annual installments commencing on January 5, 2012, which was the first anniversary of the grant date.
The option vested in three approximately equal annual installments commencing on January 7, 2014, which was the first anniversary of the grant date.
The option vested and became exercisable in the amount of 3,300 shares on each of January 5, 2015 and January 6, 2016.
/s/Jodi Giordano, Attorney-in-Fact
2016-05-11